This trial is terminated!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Pulmonary Emphysema
and you are
over 40
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

The purpose of this study is to demonstrate the safety and efficacy of AeriSeal System treatment plus optimal medical therapy compared in patients with advanced upper lobe predominant (ULP) heterogeneous emphysema.

Provided treatments

  • Device: Treatment plus Optimal Medical Therapy
  • Other: Optimal Medical Therapy

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01449292. The sponsor of the trial is Aeris Therapeutics and it is looking for 300 volunteers for the current phase.
Official trial title:
Study of the AeriSeal System for HyPerInflation Reduction in Emphysema (ASPIRE)